New polypill to tackle cardiovascular disease

Two Australian organisations will work together to develop a new four-in-one tablet, designed to reduce the impact of heart disease and strokeBupa Australia and The George Institute for Global Health have announced they are joining forces to develop a new medication with a fixed-dose combination of commonly used blood pressure and cholesterol lowering medications, along with aspirin.Research has shown